 |
|
Illness finder is a diagnostic medicine tool for educational purpose that looks up your patients' health conditions or symptoms and diagnosis and find diseases or illnesses based on chosen gender, age, risk factors, illness, signs, symptoms and prevalence. Illnessfinder is inspired by Evidence based medicine (EMB) and healthcare that aims to apply the best (most reliable) knowledge that is available at decision time. Illnessfinder aims to free up time for the therapeutic dialogue and ensure quality at the evidence based practice, uniting proven medical findings and clinical evidence with systematised data technology.
| Enter a medical term |
| Pregnancy-Specific beta 1-Glycoproteins | Legal notice |
Other terms
1-Glycoproteins, Pregnancy-Specific beta,Pregnancy Specific beta 1 Glycoproteins,beta 1-Glycoproteins, Pregnancy-Specific,Pregnancy-Specific beta 1-Glycoprotein,Pregnancy-Specific beta-1 Globulin,Pregnancy Specific beta 1 Globulin,beta-1 Globulin, Pregnancy-Specific,PSBG-1,PSBG 1,Trophoblast-Specific beta 1-Glycoprotein,Trophoblast Specific beta 1 Glycoprotein,Trophoblastic beta 1-Glycoprotein,Pregnancy Specific beta-1 Glycoprotein,Trophoblastic beta-Globulin,Trophoblastic beta Globulin,beta-Globulin, Trophoblastic,beta 1-Globulin, Trophoblast-Specific,Trophoblast-Specific beta 1-Globulin,beta 1 Globulin, Trophoblast Specific,beta 1-Glycoprotein, Pregnancy-Specific,beta-1 Glycoprotein, Trophoblast-Specific,Trophoblast-Specific beta-1 Glycoprotein,Pregnancy Specific beta 1 Glycoprotein,Pregnancy Specific beta1-Glycoprotein.,Trophoblastic beta(1)-Globulin,Pregnancy-Associated Plasma Protein C,Pregnancy Associated Plasma Protein C,Schwangerschaftsprotein 1,1, Schwangerschaftsprotein,SP1 Pregnancy Protein,Pregnancy Protein, SP1,Protein, SP1 Pregnancy,PAPP-C,Pregnancy-Associated Plasma Protein B,Pregnancy Associated Plasma Protein B,PAPP-B,PAPP B,Pregnancy-Associated beta-Plasma Protein
Description
Pregnancy-Specific beta 1-Glycoproteins: Glycoproteins with the electrophoretic mobility of BETA-GLOBULINS, secreted by the placental TROPHOBLASTS into the maternal bloodstream during PREGNANCY. They can be detected 18 days after OVULATION and reach 200 mg/ml at the end of pregnancy. They are associated with fetal well-being.
Pervious tree
Next tree
Other locations in tree
Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.